Skip to main navigation
Skip to search
Skip to main content
University of Copenhagen Research Portal Home
Help & FAQ
Dansk
English
Home
Profiles
Research output
Research units
Press/Media
Activities
Prizes
???studenttheses???
Datasets
Search by expertise, name or affiliation
Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus.
Jens Juul Holst
,
Carolyn F Deacon
Department of Biology
Department of Biomedical Sciences
Endocrinology and Metabolism
120
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Glucagon-like peptide 1 and inhibitors of dipeptidyl peptidase IV in the treatment of type 2 diabetes mellitus.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Dipeptidyl-Peptidase IV Inhibitors
83%
Glucagon-Like Peptide 1
74%
Type 2 Diabetes Mellitus
47%
Subcutaneous Infusions
20%
Therapeutics
10%
Clinical Trials
10%
Enzymes
8%
Chemical Compounds
Glucagon-Like Peptide 1
100%